本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Purple Biotech Ltd.

2.69
+0.00340.13%
盘后2.690.00000.00%18:57 EDT
成交量:1.14万
成交额:3.06万
市值:711.04万
市盈率:-0.61
高:2.78
开:2.70
低:2.64
收:2.68
数据加载中...
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/07/17

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/31

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals